Can a nerve stimulator beat tough depression? new study tracks Long-Term results
NCT ID NCT03320304
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 500 people with treatment-resistant depression who receive Vagus Nerve Stimulation (VNS) Therapy, an implanted device that sends electrical pulses to the vagus nerve. Researchers will track how many patients see a 50% or greater improvement in depression scores over 12 months. The goal is to see how well VNS works in everyday medical practice, not just in controlled trials.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Vagus Nerve Stimulation (VNS) Therapy device
- What this could lead to
- If successful, this could confirm VNS Therapy as a reliable long-term option for people with treatment-resistant depression.
- What could go wrong
- This is an observational study, not a controlled trial, so results may be less conclusive. The device requires surgery and carries risks like infection or nerve damage.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TREATMENT RESISTANT DEPRESSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AKH Allgemeines Krankenhaus der Stadt Wien
RECRUITINGVienna, 1090, Austria
-
Academic Psychiatry Wolfson Research Centre
RECRUITINGNewcastle upon Tyne, United Kingdom
-
Glenfield hospital
RECRUITINGLeicester, LE3 9EJ, United Kingdom
-
KU Leuven
RECRUITINGLeuven, Belgium
-
King's College London
RECRUITINGLondon, United Kingdom
-
Klinikum Wilhelmshaven
ACTIVE_NOT_RECRUITINGWilhelmshaven, Germany
-
LVR-Hospital Essen
RECRUITINGEssen, 45147, Germany
-
Medizinische Hochschule Hannover
WITHDRAWNHanover, Germany
-
Mendip HTT / St Andrew's Ward
ACTIVE_NOT_RECRUITINGWells, BA5 1TH, United Kingdom
-
Sozialstiftung Bamberg - Klinikum am Bruderwald
WITHDRAWNBamberg, Germany
-
University Hospital Münster
RECRUITINGMünster, Germany
-
Universitätsklinik Leipzig
RECRUITINGLeipzig, 04103, Germany
-
Universitätsklinikum Bonn
RECRUITINGBonn, Germany
-
Universitätsklinikum Frankfurt
RECRUITINGFrankfurt, Germany
-
Universitätsklinikum Freiburg
COMPLETEDFreiburg im Breisgau, Germany
-
Universitätsklinikum Jena
COMPLETEDJena, Germany
-
Universitätsklinikum Köln
RECRUITINGCologne, Germany
-
Universitätsmedizin Göttingen
WITHDRAWNGöttingen, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Brain 'Radio' tunes into Depression's neural signals
- Magic mushroom compound tested for dual relief of chronic pain and depression
- Ketamine plus talk therapy shows promise for stubborn depression
- Brain zaps guided by scans: a new hope for untreatable depression?
- Magic mushroom compound may offer new hope for stubborn depression
- Can a blood test predict who will respond to ketamine for depression?